Pilot study assessing the impact of intrathecal baclofen administration mode on sleep-related respiratory parameters.

[1]  B. Leduc,et al.  Estimated prevalence of obstructive sleep apnea-hypopnea syndrome after cervical cord injury. , 2007, Archives of physical medicine and rehabilitation.

[2]  B. Bussel,et al.  Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity , 2006, Neurology.

[3]  S. Kothare,et al.  Intrathecal Baclofen Overdose and Withdrawal , 2006, Pediatric emergency care.

[4]  B. Bussel,et al.  Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients , 2006, Multiple sclerosis.

[5]  David J Berlowitz,et al.  A longitudinal evaluation of sleep and breathing in the first year after cervical spinal cord injury. , 2005, Archives of physical medicine and rehabilitation.

[6]  C. Pollak,et al.  Sleep Disorders in Multiple Sclerosis , 2005, Seminars in neurology.

[7]  F. Michel,et al.  Characteristics of sleep apnea syndrome in tetraplegic patients , 2002, Spinal Cord.

[8]  Daniel J Buysse,et al.  Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research , 2000 .

[9]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[10]  M. Staal,et al.  Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity , 1997, Journal of neurology, neurosurgery, and psychiatry.

[11]  P. Lespérance,et al.  Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria , 1997, Movement disorders : official journal of the Movement Disorder Society.

[12]  R. Mcevoy,et al.  The effects of the GABA agonist, baclofen, on sleep and breathing. , 1995, The European respiratory journal.

[13]  C. Guilleminault,et al.  Atlas and scoring rules , 1993 .

[14]  R. Penn,et al.  The distribution of medication along the spinal canal after chronic intrathecal administration. , 1993, Neurosurgery.

[15]  J. Gybels,et al.  Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[16]  M. Latash,et al.  Intrathecal Baclofen for Severe Spinal Spasticity , 1989, The New England journal of medicine.

[17]  P. Cowen,et al.  Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis. , 1988, Sleep.

[18]  P. Lalley.  Effects of baclofen and γ-aminobutyric acid on different types of medullary respiratory neurons , 1986, Brain Research.

[19]  H. Kazemi,et al.  Reversible depression of ventilation and cardiovascular function by ventriculocisternal perfusion with gamma-aminobutyric acid in dogs. , 1986, The American review of respiratory disease.

[20]  R. Penn,et al.  INTRATHECAL BACLOFEN ALLEVIATES SPINAL CORD SPASTICITY , 1984, The Lancet.

[21]  T. Hedner,et al.  An analysis of the mechanism by which gamma-aminobutyric acid depresses ventilation in the rat. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[22]  K. A. Yamada,et al.  Respiratory depression produced by activation of GABA receptors in hindbrain of cat. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.

[23]  E. Wolpert.  A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. , 1969 .

[24]  B. Ashworth.  PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS. , 1964, The Practitioner.

[25]  V. Kapur,et al.  Factors associated with sleep apnea in men with spinal cord injury: a population-based case-control study , 2001, Spinal Cord.

[26]  B. Bussel,et al.  Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. , 1996, Archives of physical medicine and rehabilitation.

[27]  C. Guilleminault,et al.  EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. , 1992, Sleep.

[28]  R. Penn,et al.  Functional outcome after delivery of intrathecal baclofen. , 1989, Archives of physical medicine and rehabilitation.

[29]  E. Freireich,et al.  Subarachnoid Distribution of Drugs After Lumbar Injection. , 1963, Canadian Medical Association journal.